These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 10759020
1. The low dose (1 microg) ACTH stimulation test for assessment of the hypothalamo-pituitary-adrenal axis. Beishuizen A, van Lijf JH, Lekkerkerker JF, Vermes I. Neth J Med; 2000 Mar; 56(3):91-9. PubMed ID: 10759020 [Abstract] [Full Text] [Related]
2. A comparison between the 1-microg adrenocorticotropin (ACTH) test, the short ACTH (250 microg) test, and the insulin tolerance test in the assessment of hypothalamo-pituitary-adrenal axis immediately after pituitary surgery. Dökmetaş HS, Colak R, Keleştimur F, Selçuklu A, Unlühizarci K, Bayram F. J Clin Endocrinol Metab; 2000 Oct; 85(10):3713-9. PubMed ID: 11061529 [Abstract] [Full Text] [Related]
3. Low-dose (1 microgram) adrenocorticotrophin (ACTH) stimulation as a screening test for impaired hypothalamo-pituitary-adrenal axis function: sensitivity, specificity and accuracy in comparison with the high-dose (250 microgram) test. Tordjman K, Jaffe A, Trostanetsky Y, Greenman Y, Limor R, Stern N. Clin Endocrinol (Oxf); 2000 May; 52(5):633-40. PubMed ID: 10792344 [Abstract] [Full Text] [Related]
4. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests. Maghnie M, Uga E, Temporini F, Di Iorgi N, Secco A, Tinelli C, Papalia A, Casini MR, Loche S. Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359 [Abstract] [Full Text] [Related]
5. The low-dose ACTH test does not provide a useful assessment of the hypothalamic-pituitary-adrenal axis in secondary adrenal insufficiency. Suliman AM, Smith TP, Labib M, Fiad TM, McKenna TJ. Clin Endocrinol (Oxf); 2002 Apr; 56(4):533-9. PubMed ID: 11966747 [Abstract] [Full Text] [Related]
6. A comparison between low-dose (1 microg), standard-dose (250 microg) ACTH stimulation tests and insulin tolerance test in the evaluation of hypothalamo-pituitary-adrenal axis in primary fibromyalgia syndrome. Kirnap M, Colak R, Eser C, Ozsoy O, Tutus A, Kelestimur F. Clin Endocrinol (Oxf); 2001 Oct; 55(4):455-9. PubMed ID: 11678827 [Abstract] [Full Text] [Related]
7. Comparison of low dose and standard dose adrenocorticotropin stimulation tests in healthy Nigerians. Odeniyi IA, Fasanmade OA, Ajala MO, Ohwovoriole AE. Afr J Med Med Sci; 2010 Jun; 39(2):113-8. PubMed ID: 21117407 [Abstract] [Full Text] [Related]
8. The one microgram adrenocorticotropin test in the assessment of hypothalamic-pituitary-adrenal function. Ambrosi B, Barbetta L, Re T, Passini E, Faglia G. Eur J Endocrinol; 1998 Dec; 139(6):575-9. PubMed ID: 9916859 [Abstract] [Full Text] [Related]
9. Hypothalamus-pituitary-adrenal axis evaluation in patients with hypothalamo-pituitary disorders: comparison of different provocative tests. Giordano R, Picu A, Bonelli L, Balbo M, Berardelli R, Marinazzo E, Corneli G, Ghigo E, Arvat E. Clin Endocrinol (Oxf); 2008 Jun; 68(6):935-41. PubMed ID: 18031311 [Abstract] [Full Text] [Related]
10. A comparison between the effects of low (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal cortex functions with Behçet's disease. Colak R, Ozkan Y, Cengiz SU, Saral Y, Kandi BC, Halifeoglu I. J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):721-5. PubMed ID: 16836503 [Abstract] [Full Text] [Related]
11. The low dose (1-microg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. Thaler LM, Blevins LS. J Clin Endocrinol Metab; 1998 Aug; 83(8):2726-9. PubMed ID: 9709938 [Abstract] [Full Text] [Related]
12. Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. Calis M, Gökçe C, Ates F, Ulker S, Izgi HB, Demir H, Kirnap M, Sofuoglu S, Durak AC, Tutus A, Kelestimur F. J Endocrinol Invest; 2004 Jan; 27(1):42-6. PubMed ID: 15053242 [Abstract] [Full Text] [Related]
13. The overnight single-dose metyrapone test is a simple and reliable index of the hypothalamic-pituitary-adrenal axis. Fiad TM, Kirby JM, Cunningham SK, McKenna TJ. Clin Endocrinol (Oxf); 1994 May; 40(5):603-9. PubMed ID: 8013141 [Abstract] [Full Text] [Related]
14. Is the plasma ACTH concentration a reliable parameter in the insulin tolerance test? Borm K, Slawik M, Seiler L, Flohr F, Petrick M, Honegger J, Reincke M. Eur J Endocrinol; 2003 Dec; 149(6):535-41. PubMed ID: 14640994 [Abstract] [Full Text] [Related]
15. Evaluation of hypothalamic-pituitary-adrenal axis suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid. Ozbek OY, Turktas I, Bakirtas A, Bideci A. J Pediatr Endocrinol Metab; 2006 Aug; 19(8):1015-23. PubMed ID: 16995587 [Abstract] [Full Text] [Related]
16. Diagnostic usefulness of the growth hormone-releasing peptide-2 test as a substitute for the insulin tolerance test in hypopituitarism. Kageyama K, Nigawara T, Sakihara S, Takayasu S, Terui K, Moriyama T, Suda T. Endocr J; 2008 Aug; 55(4):777-83. PubMed ID: 18493103 [Abstract] [Full Text] [Related]
17. The relationship between morning serum cortisol and the short ACTH test in the evaluation of adrenal insufficiency. Lee MT, Won JG, Lee TI, Yang HJ, Lin HD, Tang KT. Zhonghua Yi Xue Za Zhi (Taipei); 2002 Dec; 65(12):580-7. PubMed ID: 12636203 [Abstract] [Full Text] [Related]
18. Testing the hypothalamic-pituitary-adrenal axis in survivors of childhood brain and skull-based tumors. Shankar RR, Jakacki RI, Haider A, Lee MW, Pescovitz OH. J Clin Endocrinol Metab; 1997 Jun; 82(6):1995-8. PubMed ID: 9177419 [Abstract] [Full Text] [Related]
19. The assessment of the hypothalamo-pituitary-adrenal axis in pituitary disease: are there short cuts? Dickstein G. J Endocrinol Invest; 2003 Jun; 26(7 Suppl):25-30. PubMed ID: 14604063 [Abstract] [Full Text] [Related]
20. Comment on comparison of the low dose short synacthen test (1 microg), the conventional dose short synacthen test (250 microg), and the insulin tolerance test for assessment of the hypothalamo-pituitary-adrenal axis in patients with pituitary disease. Oelkers W. J Clin Endocrinol Metab; 1999 Aug; 84(8):2973-4. PubMed ID: 10443706 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]